[EFFECT] Autonomix Medical, Inc. SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

EFFECT

Rhea-AI Filing Summary

07/14/2025 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 11, 2025

Accession Number:

0001437749-25-022165

Submission Type:

POS AM

CIK:	0001617867
Company Name:	Autonomix Medical, Inc.
File Number:	333-282940

Source: View Original Filing on SEC EDGAR

Autonomix Medical Inc

NASDAQ:AMIX

AMIX Rankings

#10345 Ranked by Market Cap

N/A Ranked by Dividends

AMIX Latest News

Jul 7, 2025

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Jun 30, 2025

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 27, 2025

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 5, 2025

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

May 15, 2025

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

AMIX Latest SEC Filings

Jul 3, 2025

[POS AM] Autonomix Medical, Inc. SEC Filing

AMIX Stock Data

Market Cap 6.07M

Float 2.30M

Insiders Ownership 19.52%

Institutions Ownership 19.89%

Short Percent 3.08%

Industry Medical Devices

Sector Surgical & Medical Instruments & Apparatus

Website Link

Country United States

City THE WOODLANDS